Molecular Cancer

Call for Papers: New Thematic Series

For the third consecutive year, Molecular Cancer is excited to announce a new thematic series covering the general research area of Non-coding RNAs and RNA modifiers in cancer progression and cancer cells resistance to therapies. Of particular focus are original research papers reporting data from clinical trials or animal models. In addition to original research articles, we aim to publish letters to the Editor and comprehensive reviews.

All submitted manuscripts will undergo rigorous initial evaluation within 7 days, and then, when appropriate, will be sent out for external peer review to assess the suitability for publication. Submit here.

Submission deadline: December 15^th, 2019

Expected publication date: February 2020

Thematic Series Published in 2019: Microvesicles and Tumor Microenvironment in Cancer Development and Resistance to Therapies

This series of review articles aims to highlight significant findings and advances in our understanding of the role of the TME in cancer biology. The tumor microenvironment (TME) has an effect on tumor development, growth, and resistance to therapy. Continuous interactions and exchanges between tumor cells and the TME are involved in angiogenesis, tumor genetic diversity, immune escape, and metastasis.

Featured Article: Role of the NLRP3 inflammasome in cancer

In this review, Sahebkar et al. summarize the current knowledge on the contribution of the NLRP3 inflammasome on potential cancer promotion and therapy.

Thematic Series Published in 2018

Series of Review Articles: Oncogenic Signaling of Tyrosine Kinase in Cancer: Challenges and Therapeutic Opportunities

EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression

Authors: Shunli Peng, Rong Wang, Xiaojuan Zhang, Yueyun Ma, Longhui Zhong, Ke Li, Akihiro Nishiyama, Sachiko Arai, Seiji Yano and Wei Wang

Content type: Research

20 November 2019
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

Authors: Jiajie Hou, He Zhang, Jun Liu, Zhenjun Zhao, Jianye Wang, Zhike Lu, Bian Hu, Jiankui Zhou, Zhicong Zhao, Mingxuan Feng, Haiyan Zhang, Bin Shen, Xingxu Huang, Beicheng Sun, Chuan He and Qiang Xia

Content type: Research

18 November 2019
circLMTK2 acts as a sponge of miR-150-5p and promotes proliferation and metastasis in gastric cancer

Authors: Sen Wang, Dong Tang, Wei Wang, Yining Yang, Xiaoqing Wu, Liuhua Wang and Daorong Wang

Content type: Research

14 November 2019
m⁶A modification suppresses ocular melanoma through modulating HINT2 mRNA translation

Authors: Ruobing Jia, Peiwei Chai, Shanzheng Wang, Baofa Sun, Yangfan Xu, Ying Yang, Shengfang Ge, Renbing Jia, Yun-Gui Yang and Xianqun Fan

Content type: Research

14 November 2019
circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling

Authors: Xueting Hu, Duoguang Wu, Xiaotian He, Huiying Zhao, Zhanghai He, Jiatong Lin, Kefeng Wang, Wenjian Wang, Zihao Pan, Huayue Lin and Minghui Wang

Content type: Research

14 November 2019

Most recent articles RSS

View all articles

Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer

Authors: Ruochuan Sun, Jifeng Wu, Yuanyuan Chen, Mingdian Lu, Shangxin Zhang, Daru Lu and Yongxiang Li

Content type: Research

28 September 2014
The complexity of NF-κB signaling in inflammation and cancer

Authors: Bastian Hoesel and Johannes A Schmid

Content type: Review

2 August 2013
Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer

Authors: Donatella Del Bufalo, Marianna Desideri, Teresa De Luca, Marta Di Martile, Chiara Gabellini, Valentina Monica, Simone Busso, Adriana Eramo, Ruggero De Maria, Michele Milella and Daniela Trisciuoglio

Content type: Research

9 October 2014
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

Authors: María M Caffarel, Clara Andradas, Emilia Mira, Eduardo Pérez-Gómez, Camilla Cerutti, Gema Moreno-Bueno, Juana M Flores, Isabel García-Real, José Palacios, Santos Mañes, Manuel Guzmán and Cristina Sánchez

Content type: Research

22 July 2010
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Authors: Mildred Felder, Arvinder Kapur, Jesus Gonzalez-Bosquet, Sachi Horibata, Joseph Heintz, Ralph Albrecht, Lucas Fass, Justanjyot Kaur, Kevin Hu, Hadi Shojaei, Rebecca J Whelan and Manish S Patankar

Content type: Review

29 May 2014

Most accessed articles RSS

View all articles

Editor-in-Chief

Christophe Nicot, Kansas University Medical Center, USA

Aims and scope

Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.

Molecular Cancer

Call for Papers: New Thematic Series

Thematic Series Published in 2019: Microvesicles and Tumor Microenvironment in Cancer Development and Resistance to Therapies

Featured Article: Role of the NLRP3 inflammasome in cancer

Thematic Series Published in 2018

Articles

EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression

YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

circLMTK2 acts as a sponge of miR-150-5p and promotes proliferation and metastasis in gastric cancer

m⁶A modification suppresses ocular melanoma through modulating HINT2 mRNA translation

circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling

Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer

The complexity of NF-κB signaling in inflammation and cancer

Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Editor-in-Chief

Aims and scope

Follow

Annual Journal Metrics

Molecular Cancer

Contact us